ID

31316

Description

Study ID: 104574 Clinical Study ID: AR1104574 Study Title: A randomized blinded pilot trial of fondaparinux sodium (Arixtra®) versus unfractionated heparin in addition to standard therapy in a broad range of patients undergoing percutaneous coronary intervention (ASPIRE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: fondaparinux sodium Trade Name: Arixtra Study Indication: Thromboembolism

Keywords

Versions (1)
  1. 8/13/18 8/13/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

August 13, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Fondaparinux sodium (Arixtra) versus unfractionated heparin with patients undergoing PCI; Clinical Study ID: AR1104574

English

Study Completion/Investigator's Final Statement

1 forms  
Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Patient ID, Centre No.
Description

Patient ID; Centre Number

Data type

text

Alias
UMLS CUI [1,1]
C1269815
UMLS CUI [1,2]
C2825181
UMLS CUI [1,3]
C1300638
Patient ID, Envelope No.
Description

Patient ID; Envelope Number

Data type

text

Alias
UMLS CUI [1,1]
C1269815
UMLS CUI [1,2]
C2348585
Patient Initials
Description

Patient Initials

Data type

text

Alias
UMLS CUI [1]
C2986440
Final statement
Description

Final statement

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C1710187
Was the study drug unblinded at any time during the study?
Description

study drug unblinded

Data type

text

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C3897431
Did patient withdraw consent during the study?
Description

consent withdrawn

Data type

text

Alias
UMLS CUI [1]
C1707492
Additional comments
Description

Comment

Data type

text

Alias
UMLS CUI [1]
C0947611
Investigator's signature
Description

Investigator's signature

Data type

text

Alias
UMLS CUI [1]
C2346576
Please print investigator last name in block capitals
Description

investigator last name

Data type

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C1301584
Date of signature
Description

Investigator signature, date

Data type

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Back to the top of the page

Similar models

Study Completion/Investigator's Final Statement

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Patient ID; Centre Number
Item
Patient ID, Centre No.
text
C1269815 (UMLS CUI [1,1])
C2825181 (UMLS CUI [1,2])
C1300638 (UMLS CUI [1,3])
Patient ID; Envelope Number
Item
Patient ID, Envelope No.
text
C1269815 (UMLS CUI [1,1])
C2348585 (UMLS CUI [1,2])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Final statement
C0008961 (UMLS CUI-1)
C1710187 (UMLS CUI-2)
Item
Was the study drug unblinded at any time during the study?
text
C0304229 (UMLS CUI [1,1])
C3897431 (UMLS CUI [1,2])
study drug unblinded
Code List
Was the study drug unblinded at any time during the study?
CL Item
No (No)
CL Item
Yes (Specify) (Yes (Specify))
Item
Did patient withdraw consent during the study?
text
C1707492 (UMLS CUI [1])
consent withdrawn
Code List
Did patient withdraw consent during the study?
CL Item
No (No)
CL Item
Yes (give date) (Yes (give date))
Comment
Item
Additional comments
text
C0947611 (UMLS CUI [1])
Investigator's signature
Item
Investigator's signature
text
C2346576 (UMLS CUI [1])
investigator last name
Item
Please print investigator last name in block capitals
text
C0008961 (UMLS CUI [1,1])
C1301584 (UMLS CUI [1,2])
Investigator signature, date
Item
Date of signature
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial